LX4211 increases serum glucagon-like peptide 1 and peptide YY levels by reducing sodium/glucose cotransporter 1 (SGLT1)-mediated absorption of intestinal glucose
Yang WS, SriRamaratnam R, Welsch ME, Shimada K, Skouta R, Viswanathan VS, et al
Monitoring glucose levels, including fasting insulin and HbA1c, helps to assess metabolic health (1)
The tracer was used in a clinical trial in combination with a Glucagon like peptide-1 (GLP-1) receptor tracer to assess the receptor occupancy of the dual GLP1/GCG receptor agonist SAR425899
Sonu olarak, glutatyon, vcudun doal savunma mekanizmalarnn nemli bir paras olup, salkl bir yaam iin bu seviyelerin korunmas byk nem tar